JP2006516259A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006516259A5 JP2006516259A5 JP2005501081A JP2005501081A JP2006516259A5 JP 2006516259 A5 JP2006516259 A5 JP 2006516259A5 JP 2005501081 A JP2005501081 A JP 2005501081A JP 2005501081 A JP2005501081 A JP 2005501081A JP 2006516259 A5 JP2006516259 A5 JP 2006516259A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- agent
- cancer cell
- growth
- inhibits
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 6
- 238000000034 method Methods 0.000 claims 10
- 239000003795 chemical substances by application Substances 0.000 claims 7
- 206010028980 Neoplasm Diseases 0.000 claims 6
- 201000011510 cancer Diseases 0.000 claims 6
- 230000002401 inhibitory effect Effects 0.000 claims 5
- 102000005698 Frizzled receptors Human genes 0.000 claims 4
- 108010045438 Frizzled receptors Proteins 0.000 claims 4
- 108050003627 Wnt Proteins 0.000 claims 3
- 102000013814 Wnt Human genes 0.000 claims 3
- 230000005907 cancer growth Effects 0.000 claims 3
- 150000001875 compounds Chemical class 0.000 claims 3
- 230000000694 effects Effects 0.000 claims 3
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 2
- 230000003834 intracellular effect Effects 0.000 claims 2
- 201000005202 lung cancer Diseases 0.000 claims 2
- 208000020816 lung neoplasm Diseases 0.000 claims 2
- 108020004459 Small interfering RNA Proteins 0.000 claims 1
- 101150019524 WNT2 gene Proteins 0.000 claims 1
- 102000052556 Wnt-2 Human genes 0.000 claims 1
- 108700020986 Wnt-2 Proteins 0.000 claims 1
- 239000000654 additive Substances 0.000 claims 1
- 230000000996 additive effect Effects 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 238000012216 screening Methods 0.000 claims 1
- 229920001184 polypeptide Polymers 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 210000004896 polypeptide structure Anatomy 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26482502A | 2002-10-04 | 2002-10-04 | |
| US49135003P | 2003-07-31 | 2003-07-31 | |
| PCT/US2003/031384 WO2004032838A2 (en) | 2002-10-04 | 2003-10-03 | Methods for treating cancer by inhibiting wnt signaling |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006516259A JP2006516259A (ja) | 2006-06-29 |
| JP2006516259A5 true JP2006516259A5 (enExample) | 2007-01-18 |
Family
ID=34315989
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005501081A Pending JP2006516259A (ja) | 2002-10-04 | 2003-10-03 | Ｗｎｔシグナル伝達の抑制によって癌を治療するための方法 |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JP2006516259A (enExample) |
| AU (1) | AU2003299921A1 (enExample) |
| HK (1) | HK1078739A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101285259B1 (ko) * | 2011-08-04 | 2013-07-11 | (주)케어젠 | Ｗｎｔ 계열 유래 펩타이드 및 이의 용도 |
| JP7325075B2 (ja) * | 2018-09-21 | 2023-08-14 | 学校法人 埼玉医科大学 | フリズルド３発現細胞の細胞数増加剤若しくは低下剤、糖尿病予防若しくは治療剤、インスリノーマ予防若しくは治療剤、及びインスリン分泌促進剤若しくは分泌抑制剤よりなる群から選択される少なくとも１つの剤をスクリーニングするためのスクリーニング剤、スクリーニング用キット、及びスクリーニング方法 |
-
2003
- 2003-10-03 HK HK06100227.9A patent/HK1078739A1/zh unknown
- 2003-10-03 JP JP2005501081A patent/JP2006516259A/ja active Pending
- 2003-10-03 AU AU2003299921A patent/AU2003299921A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Nagata et al. | Cellular localization and expression of template-activating factor I in different cell types | |
| ES2625316T3 (es) | Neuquinasa, una proteína corriente abajo de neuregulina | |
| US9366667B2 (en) | Piscine reovirus diagnostic compositions | |
| Reeves | Antibodies to the p70/p80 (Ku) antigens in systemic lupus erythematosus | |
| BRPI0612273B8 (pt) | anticorpo de ligação a il-1 beta ou fragmento de ligação a il-1 beta do mesmo, ácido nucleico, vetor, e, composição | |
| JP2009540852A5 (enExample) | ||
| JP2004536585A5 (enExample) | ||
| Grosso et al. | Peptide sequences selected by BA4, a tropoelastin-specific monoclonal antibody, are ligands for the 67-kilodalton bovine elastin receptor | |
| RU2018138782A (ru) | Антитела к фактору ix padua | |
| Michael et al. | All eight unassigned reading frames of mouse mitochondrial DNA are expressed. | |
| St Clair et al. | Temporal correlation of antibody responses to different epitopes of the human La autoantigen. | |
| Muro et al. | Synthetic compound peptide simulating antigenicity of conformation-dependent autoepitope | |
| JP2004520270A (ja) | ヒストン中のメチル化されたリジンに特異的な抗体 | |
| JP2006516259A5 (enExample) | ||
| Honoré et al. | hnRNPs H, H′ and F behave differently with respect to posttranslational cleavage and subcellular localization | |
| Onoue et al. | Heterooligomer of type 1 and type 2 inositol 1, 4, 5-trisphosphate receptor expressed in rat liver membrane fraction exists as tetrameric complex | |
| JP2005509160A5 (enExample) | ||
| US6413934B1 (en) | Streptavidin mutants having secondary functional domains | |
| JP2004500055A5 (enExample) | ||
| JP2008509659A5 (enExample) | ||
| Miyake‐Nishijima et al. | Role of Crk‐associated substrate lymphocyte type in the pathophysiology of rheumatoid arthritis in tax transgenic mice and in humans | |
| US5624905A (en) | Merosin fragments and uses thereof | |
| JPS63264600A (ja) | ウシ白血病ウイルスに対する感染防御抗体を誘導するペプチド分画と、この分画を得る方法と、この分画の遺伝暗号配列と、この分画から製造されるワクチン | |
| Leung et al. | Inhibition of PDC-E2 human combinatorial autoantibodies by peptide mimotopes | |
| Hattori et al. | Generation of monoclonal antibodies against mitocryptide‐2: toward a new strategy to investigate the biological roles of cryptides |